Pragmatic evaluation of effectiveness and acceptability of the Bristol Medication Review toolkit

niversity of Bristol0 个研究点目标入组 8,000,000 人开始时间: 2024年6月3日最近更新: 2024年7月15日

适应症

试验速览

暂无简介。

•1. General practices using EMIS or SystmOne clinical systems, and contributing to the secure data processing environment of the nationally representative Oxford-Royal College of GPs Clinical Informatics Digital Hub (ORCHID), will be eligible to participate in the trial. All patients aged =18 years who have not registered with their practice an opt-out of sharing data outside of the practice for purposes of research or planning, will be included in the main trial analysis.
•2. Within the 56 practices participating in the process evaluation, all adult patients (aged =18 years) receiving a structured medication review during four 2-week blocks within the 12-month intervention period will be sent a patient-experience questionnaire, and all adult patients receiving a review within the 12-month intervention period will be sent a quality of life questionnaire. Additionally, a smaller number of patients will be approached and invited to provide consent to participate in an interview.

•1. Patients aged 17 years and under
•2. Patients who have registered with their practice an opt-out of sharing data outside of the practice for purposes of research or planning

发起方

niversity of Bristol